Welcome to the Amprion 2024 landing page! From here you can download through the links below or explore the rest of our website.
Thank you for joining us at the
International Congress of Parkinson’s Disease and Movement Disorders 2024, booth #318
July 28-August 1, 2024 | Philadelphia, PA
Don't miss these presentations at the
International Congress of Parkinson's Disease
and Movement Disorders 2024!
Abstract 21: Seed Amplification Assay for the Differentiation of αSyn Seed Subtypes
Presentation: Saturday, Sept. 28, 1-3 pm EDT
Carly Farris, Amprion
Abstract 60: Identification of Underlying Lewy Body Pathology in Primary Tauopathies by α-Synuclein Seed Amplification Assay
Poster Presentation: Saturday, Sept. 28, 1-3 pm EDT
Luis Concha, Amprion
Abstract 95: α-Synuclein Seed Amplification Assay Amplification Parameters and Progression in Parkinson’s Disease
Poster Presentation: Saturday, Sept. 28, 1-3 pm EDT
Oral Platform Presentation: Monday, Sept. 30, 1:30-2:30 pm EDT
David Coughlin, UCSD
Abstract 123: α-Synuclein Pathology Across Movement Disorders and Neurodegenerative Diseases by Seed Amplification Assay
Poster Presentation: Saturday, Sept. 28 1-3 pm EDT
Oral Presentation: Monday, Sept. 30, 1-3 pm EDT
Sandrina Weber, University Medical Center Goettingen
Abstract 128: Association Between Kinetic Parameters of alpha-Synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes
Poster Presentation: Saturday, Sept. 30, 1-3 pm EDT
Piergiorgio Grillo, University of Pavia
Abstract 229: Cognitive Performance in Early Neuronal alpha-Synuclein Disease
Poster Presentation: Saturday, Sept. 28, 1-3 pm EDT
Daniel Weintraub, University of Pennsylvania School of Medicine
Abstract 713: Remote Recruitment of Hyposmic Participants Identifies Biomarkers Related to Neuronal alpha-Synuclein Disease
Poster Presentation: Sunday, Sept. 29, 1-3 pm EDT
Ethan Brown, UCSF
Abstract 739: Comparison of Olfactory Testing and PSG for Detection of alpha-Synuclein Pathology in Patients With Dream Enactment Behavior or REM Sleep Behavior Disorder
Poster Presentation: Sunday, Sept. 29, 1-3 pm EDT
Ethan Brown, UCSF
Abstract 1907: Hyposmia Is Associated With Positive CSF α-Synuclein Seeding in Normal Pressure Hydrocephalus
Poster Presentation: Monday, Sept. 30th, 1-3 pm EDT
Sandrina Weber, University Medical Center Goettingen
COMING SOON!
Our findings suggest that a sub-group of ALS occurs in which self-replicating α-Syn is detectable and likely contributes to its pathogenesis
“Eur J Neurol, April 2024”
Biomarkers for α-synucleinopathies that reflect underlying pathology are sorely needed to improve the accuracy of early diagnosis and identify subtypes based on molecular factors and thus accelerate clinical trials.
“Movement Disorders, June 2023”
Misfolded α-synuclein (αSyn) aggregates (αSyn-seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies
“Mov Disord. 2023”
The purpose of this study was to determine the sensitivity and specificity of α-synuclein seed amplification
“Ann Neurol. 2022”
